Predicted protein targets (top 12)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | HTR1B | P28222 | 7/20 | 0.49 |
| ▸ | MCHR1 | Q99705 | 2/20 | 0.48 |
| ▸ | HTR1D | P28221 | 2/20 | 0.47 |
| ▸ | CNR1 | P21554 | 2/20 | 0.46 |
| ▸ | CNR2 | P34972 | 2/20 | 0.46 |
| ▸ | SLC6A4 | P31645 | 2/20 | 0.46 |
| ▸ | KCNA3 | P22001 | 1/20 | 0.45 |
| ▸ | TLR8 | Q9NR97 | 1/20 | 0.45 |
| ▸ | CYP2C9 | P11712 | 1/20 | 0.44 |
| ▸ | HRH1 | P35367 | 1/20 | 0.43 |
| ▸ | MAPT | P10636 | 1/20 | 0.43 |
| ▸ | EGFR | P00533 | 1/20 | 0.43 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL17919856 | 0.94 | HTR1B (0.51) | HTR1BMCHR1HTR1DCNR1CNR2 | |
| SCHEMBL4853806 | 0.82 | SMN1; SMN2 (0.45) | MAPT | |
| SCHEMBL249286 | 0.82 | KCNA3 (0.55) | HTR1BMCHR1HTR1DCNR1CNR2 | |
| SCHEMBL3696854 | 0.81 | HTR1B (0.69) | HTR1BHTR1DCNR1CNR2SLC6A4 | |
| SCHEMBL755688 | 0.81 | HTR1B (0.69) | HTR1BHTR1DCNR1CNR2SLC6A4 | |
| SCHEMBL1681954 | 0.81 | HTR1B (0.69) | HTR1BHTR1DCNR1CNR2SLC6A4 | |
| SCHEMBL18551586 | 0.81 | HTR1B (0.69) | HTR1BHTR1DCNR1CNR2SLC6A4 | |
| SCHEMBL20506760 | 0.81 | HTR1B (0.69) | HTR1BHTR1DCNR1CNR2SLC6A4 | |
| SCHEMBL10589534 | 0.81 | HTR1B (0.69) | HTR1BHTR1DCNR1CNR2SLC6A4 | |
| SCHEMBL30516172 | 0.81 | HTR1B (0.69) | HTR1BHTR1DCNR1CNR2SLC6A4 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 9 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10273234-B2 | Compounds that are S1P modulating agents and/or ATX modulating agents | BIOGEN MA INC. (US) | 2019-04-30 | — | — | US | disclosed |
| EP-2879674-B1 | COMPOUNDS THAT ARE S1P MODULATING AGENTS AND/OR ATX MODULATING AGENTS | BIOGEN MA INC (US) | 2017-11-22 | — | — | EP | disclosed |
| EP-2879674-B1 | COMPOUNDS THAT ARE S1P MODULATING AGENTS AND/OR ATX MODULATING AGENTS | BIOGEN MA INC (US) | 2017-11-22 | — | — | EP | disclosed |
| US-20150203493-A1 | COMPOUNDS THAT ARE S1P MODULATING AGENTS AND/OR ATX MODULATING AGENTS | BIOGEN IDEC MA INC. (US) | 2015-07-23 | — | — | US | disclosed |
| US-20150203493-A1 | COMPOUNDS THAT ARE S1P MODULATING AGENTS AND/OR ATX MODULATING AGENTS | BIOGEN IDEC MA INC. (US) | 2015-07-23 | — | — | US | disclosed |
| US-20150203493-A1 | COMPOUNDS THAT ARE S1P MODULATING AGENTS AND/OR ATX MODULATING AGENTS | BIOGEN IDEC MA INC. (US) | 2015-07-23 | — | — | US | disclosed |
| EP-2879674-A1 | COMPOUNDS THAT ARE S1P MODULATING AGENTS AND/OR ATX MODULATING AGENTS | Biogen MA Inc. (US) | 2015-06-10 | — | — | EP | disclosed |
| WO-2014025708-A1 | COMPOUNDS THAT ARE S1P MODULATING AGENTS AND/OR ATX MODULATING AGENTS | BIOGEN IDEC MA INC. (US) | 2014-02-13 | — | — | WO | disclosed |
| WO-2014025708-A1 | COMPOUNDS THAT ARE S1P MODULATING AGENTS AND/OR ATX MODULATING AGENTS | BIOGEN IDEC MA INC. (US) | 2014-02-13 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-10273234-B2 | Compounds that are S1P modulating agents and/or ATX modulating agents | ENPP2, S1PR1, S1PR2 | HTR1B 188/4885MCHR1 698/4885HTR1D 463/4885 |
| US-20150203493-A1 | COMPOUNDS THAT ARE S1P MODULATING AGENTS AND/OR ATX MODULATING AGENTS | ENPP2, S1PR1, S1PR2 | HTR1B 188/4885MCHR1 698/4885HTR1D 463/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.